Coronavirus: Hong Kong study finds ‘substantial’ antibody-level difference between BioNTech, Sinovac jab recipients

A major Hong Kong study has found “substantially higher” levels of antibodies in people vaccinated against Covid-19 with BioNTech jabs, compared with those who received the Chinese-made Sinovac vaccine.The presence of antibodies is a sign that the vaccine is working to protect the individual from the coronavirus.But the study’s findings have raised questions about a government plan to shorten the quarantine period for vaccinated travellers arriving in Hong Kong.Lead researcher Professor…

Read the original article at South China Morning Post